News & events.

Our news.

Filter by Category
Filter by Year
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News
June 5, 2026
2026

AbCellera Appoints Dr. Victor Sandor to its Board of Directors

Read article
News
May 11, 2026
2026

AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635

Read article
News
May 7, 2026
2026

AbCellera to Present at Upcoming Investor Conferences in May and June 2026

Read article
News
April 20, 2026
2026

AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call

Read article
News
April 1, 2026
2026

AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026

Read article
News
February 24, 2026
2026

AbCellera Reports Full Year 2025 Business Results

Read article
News
February 11, 2026
2026

AbCellera to Present at Upcoming Investor Conferences in March and April 2026

Read article
News
January 22, 2026
2026

AbCellera to Report Full Year 2025 Financial Results on February 24, 2026

Read article
News
January 12, 2026
2026

AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause

Read article
News
December 18, 2025
2025

AbCellera and Bruker Reach Global Settlement of Patent Litigation

Read article